Genelux stock price.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com2W 10W 9M. 9.03 +0.09 (+1.01%) As of 03:15PM EST. Market open. Options data is not available. View the basic GNLX option chain and compare options of Genelux Corporation on Yahoo Finance. For more information please visit www.genelux.com. Contacts. Investor Relations Kim Duffy [email protected] (909) 307-9300. Tiberend Strategic Advisors, Inc. Miriam Miller (Investors) [email protected] 212-375-2694. Ingrid Mezo (Media) [email protected] 646-604-5150. SOURCE Genelux CorporationAbout Real-Time Quotes. Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and sales data. Real-time ...Find the latest Genelux Corporation (GNLX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.

The 4 analysts with 12-month price forecasts for Genelux stock have an average target of 32.5, with a low estimate of 25 and a high estimate of 40. The average target predicts an increase of 231.63% from the current stock price of 9.80. Analyst Consensus: Strong Buy. Target Low Average Median High; Price: $25: $32.5: $35: $40: Change +155.10%In depth view into GNLX (Genelux) stock including the latest price, news, dividend history, earnings information and financials. Genelux Corp (GNLX) ... Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult ...

If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...

Jan 25, 2023 · All of the shares are being offered by Genelux. In addition, Genelux has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of its common stock at the initial public offering price less the underwriting discounts and commissions. Feb 16, 2024 · Analyst Forecast. According to 4 analysts, the average rating for GNLX stock is "Strong Buy." The 12-month stock price forecast is $32.5, which is an increase of 314.01% from the latest price. Genelux Corp stock price live 7.75, this page displays NASDAQ GNLX stock exchange data. View the GNLX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genelux Corp real time stock price chart below. You can find more details by visiting the additional pages to view ...GENELUX CORP's stock had its IPO on January 26, 2023, making it an older stock than just 0.15% of US equities in our set. ... With a price/sales ratio of 1,595.2, GENELUX CORP has a higher such ratio than 99.53% of stocks in our set. Revenue growth over the past 12 months for GENELUX CORP comes in at -97.85%, a number that bests merely 0.89% of ...

Genelux started at buy with $40 stock price target at Maxim Group MarketWatch. Wednesday, February 15, 2023. 06:30 AM ET. Genelux started at speculative buy with $10 stock price target at Benchmark MarketWatch. Monday, September 19, 2022. 09:08 AM ET. Genelux sets IPO terms, as the biotech could be valued at up to $165 millino MarketWatch. Most ...

Genelux Corp (NASDAQ: GNLX)’s stock price has gone decline by -7.15 in comparison to its previous close of 7.41, however, the company has experienced a -15.17% decrease in its stock price over the last five trading days. GlobeNewsWire reported 2023-09-07 that WESTLAKE VILLAGE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) ...

Feb 16, 2024 · A high-level overview of Genelux Corporation (GNLX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Genelux Corp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.Explore Genelux Corporation (GNLX) earnings date, Genelux Corporation stock earnings history, EPS, estimated EPS, earnings-related price changes, and more.Genelux is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or difficult-to ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

View the latest Genelux Corp. (GNLX) stock price, news, historical charts, analyst ratings and financial information from WSJ. WESTLAKE VILLAGE, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced a private placement for 900,000 ...- V2ACT Therapeutics™, LLC is a joint venture between Genelux Corporation and TVAX Biomedical, Inc. - V2ACT Immunotherapy is a proprietary immuno-oncology modality composed of Olvi-Vec (oncolytic viral immunotherapy) and TVAX Immunotherapy ® (vaccine-enhanced adoptive T cell therapy). - The patent expiry for the …Feb 16, 2024 · Analyst Forecast. According to 4 analysts, the average rating for GNLX stock is "Strong Buy." The 12-month stock price forecast is $32.5, which is an increase of 314.01% from the latest price. Find the latest historical data for Genelux Corporation Common Stock (GNLX) at Nasdaq.com.Genelux Stock Performance. NASDAQ GNLX opened at $8.25 on Friday. Genelux Co. has a 12 month low of $6.04 and a 12 month high of $40.98. The company’s 50 day moving average is $12.16 and its two ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...

Our Science. Genelux aims to provide an elegant therapeutic approach. Our oncolytic immunotherapy drug candidates are “off-the-shelf” personalized therapeutics. In other words, while we administer the same virus product to different patients, the cellular immune response generated is specific to the unique neoantigens in that patient.

Genelux Corporation (GNLX.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Genelux Corporation | Nasdaq: GNLX | Nasdaq The Genelux Corporation stock prediction for 2025 is currently $ 5.44, assuming that Genelux Corporation shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -26.53% increase in the GNLX stock price.3 days ago · Income Statement. In the last 12 months, Genelux had revenue of $238,000 and -$25.03 million in losses. Loss per share was -$1.34. Revenue. 238,000. Gross Profit. 238,000. Operating Income. Jan 26, 2023 · In addition, Genelux has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of its common stock at the initial public offering price less the underwriting ... What is the target price for Genelux (GNLX) stock? A. The latest price target for Genelux ( NASDAQ: GNLX) was reported by HC Wainwright & Co. on Monday, November 27, 2023. The analyst firm set a ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...Dec 14, 2023 · Genelux Corp GNLX Morningstar Rating Stock XNAS Rating as of Dec 14, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance... Current Price. $7.03. Price as of February 22, 2024, 1:09 p.m. ET ... Shares of Genelux ... The clinical-stage biotech company's stock closed last week at $20.35 and rose to as high as $26.93 on ...

Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... The current price Genelux (GNLX) is trading at is $12.56, which is within the analyst’s predicted range.

The Board of Directors of Genelux Corporation (the "Company") sets high standards for the Company's employees, officers and directors, as shown in the Company’s Code of Conduct. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders ...

Genelux Corp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...Find the latest Genelux Corporation (GNLX) stock quote, history, news and other vital information to help you with your stock trading and investing.Shares of Genelux Corp were trading at $13.22 on the day of Tyree's sale, giving the company a market cap of $347.328 million. While the market cap suggests a moderate-sized company, the insider ...See Genelux's detailed income statement and balance sheet. Find out their revenue, expenses and profit or loss over the last fiscal year. Genelux Stock Price, Funding, Valuation, Revenue & Financial Statements3 days ago · Income Statement. In the last 12 months, Genelux had revenue of $238,000 and -$25.03 million in losses. Loss per share was -$1.34. Revenue. 238,000. Gross Profit. 238,000. Operating Income. Stock Quote & Chart Historic Price Lookup Analyst Coverage Corporate Governance Documents & Charters ... The Board of Directors of Genelux Corporation (the "Company") sets high standards for the Company's employees, officers and directors, as shown in the Company’s Code of Conduct. Implicit in this philosophy is the importance of sound ...3 days ago · Income Statement. In the last 12 months, Genelux had revenue of $238,000 and -$25.03 million in losses. Loss per share was -$1.34. Revenue. 238,000. Gross Profit. 238,000. Operating Income. Jul 5, 2023 ... ... stock price. This is also referred to as the cash yield. Like the earnings yield, which shows the anticipated yield (or return) on a stock ...Discover historical prices for GNLX stock on Yahoo Finance. View daily, weekly or monthly format back to when Genelux Corporation stock was issued. The National Cancer Institute’s Center for Cancer Research Comparative Oncology Program has reported that as many as six million pet dogs and six million pet cats are diagnosed with cancer annually in the United States. The veterinary oncology market is estimated to reach $909.4 million by 2026, with North America expected to hold a dominant ...

Interactive chart of historical stock value for Genelux over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Genelux market value as of January 31, 2024 is $0.29B.The average one-year price target for Genelux Corporation is $34.425. The forecasts range from a low of $30.3 to a high of $42. A stock's price target is ...C'mon fellas, your share price is now down 90% off the IPO... just 6 months ... shares. Unless it debuts at a significant premium, it seems a rather obvious ...Instagram:https://instagram. systems insight manager downloadcomsumer cellularcarlson libraryja wick WESTLAKE VILLAGE, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that it will be added to the broad-market Russell 3000® Index and small-cap Russell 2000® at the conclusion of the 2023 Russell indexes annual reconstitution, … fat lipdownload yputube WESTLAKE VILLAGE, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced two key management promotions, as well as the addition of two new members to its leadership team. Joseph Cappello, Ph.D., who previously served as the …Genelux Corp's stock rating is based on fundamental analysis. Don't miss GNLX stock next rating changes... better man 6 days ago · Get Genelux Corp (GNLX.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ... Price To Cash Flow (Per Share TTM) 0.00. Total Debt ... Current Price. $7.03. Price as of February 22, 2024, 1:09 p.m. ET ... Shares of Genelux ... The clinical-stage biotech company's stock closed last week at $20.35 and rose to as high as $26.93 on ...